Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
{{output}}
Background/aim: Niraparib is an effective maintenance therapy after platinum-based chemotherapy for ovarian cancer. However, niraparib-induced anemia, particularly when severe, often leads to treatment discontinuation and reduced... ...
